Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
European Urology Focus
|
May 24, 2025
Role of Adjuvant Therapy in Current Perioperative Immunotherapy-based Trials in Bladder Cancer: A Justified Standard
Guru P Sonpavde
Hematology/Oncology Clinics of North America
|
May 7, 2021
Management of Bladder Cancer: The First Inning of a New Era of Rapid Advances
Guru P Sonpavde
The Journal of Urology
|
August 11, 2021
Editorial Comment
Christopher Russell, Guru P Sonpavde
Expert Opinion on Pharmacotherapy
|
September 1, 2020
Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinoma
Praful Ravi, Guru P Sonpavde
European Urology
|
November 22, 2024
Expanding the Reach of FGFR Inhibitors to Advance Precision Medicine in Urothelial Carcinoma
Vadim S Koshkin, Guru P Sonpavde
European Urology Focus
|
March 27, 2019
Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy
Bradley A McGregor, Guru P Sonpavde
JCO Precision Oncology
|
May 28, 2026
Unleashing Precision Oncology in the Development of Human Epidermal Growth Factor Receptor 2-Targeted Antibody Drug Conjugates for Urothelial Carcinoma
Bradley A McGregor, Guru P Sonpavde
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2024
Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey"
Giulia Claire Giudice, Guru P Sonpavde
Human Vaccines & Immunotherapeutics
|
July 23, 2024
Vaccine approaches to treat urothelial cancer
Giulia Claire Giudice, Guru P Sonpavde
The Journal of Urology
|
May 4, 2021
Editorial Comment
Charlene M Mantia, Guru P Sonpavde
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
European Urology Focus
|
May 24, 2025
Role of Adjuvant Therapy in Current Perioperative Immunotherapy-based Trials in Bladder Cancer: A Justified Standard
Guru P Sonpavde
Hematology/Oncology Clinics of North America
|
May 7, 2021
Management of Bladder Cancer: The First Inning of a New Era of Rapid Advances
Guru P Sonpavde
The Journal of Urology
|
August 11, 2021
Editorial Comment
Christopher Russell, Guru P Sonpavde
Expert Opinion on Pharmacotherapy
|
September 1, 2020
Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinoma
Praful Ravi, Guru P Sonpavde
European Urology
|
November 22, 2024
Expanding the Reach of FGFR Inhibitors to Advance Precision Medicine in Urothelial Carcinoma
Vadim S Koshkin, Guru P Sonpavde
European Urology Focus
|
March 27, 2019
Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy
Bradley A McGregor, Guru P Sonpavde
JCO Precision Oncology
|
May 28, 2026
Unleashing Precision Oncology in the Development of Human Epidermal Growth Factor Receptor 2-Targeted Antibody Drug Conjugates for Urothelial Carcinoma
Bradley A McGregor, Guru P Sonpavde
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2024
Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey"
Giulia Claire Giudice, Guru P Sonpavde
Human Vaccines & Immunotherapeutics
|
July 23, 2024
Vaccine approaches to treat urothelial cancer
Giulia Claire Giudice, Guru P Sonpavde
The Journal of Urology
|
May 4, 2021
Editorial Comment
Charlene M Mantia, Guru P Sonpavde
Page
of 10